|Table of Contents|

Novel cancer therapeutics for the future decade

Journal Of Modern Oncology[ISSN:1672-4992/CN:61-1415/R]

Issue:
2023 06
Page:
1170-1172
Research Field:
Publishing date:

Info

Title:
Novel cancer therapeutics for the future decade
Author(s):
ZHANG Baihong1YUE Hongyun2
1.Department of Oncology;2.Department of Ophthalmology,the 940th Hospital of Joint Logistics Support Force of People' s Liberation Army,Gansu Lanzhou 730050,China.
Keywords:
cancertherapeuticsprecise medicine
PACS:
R730.5
DOI:
10.3969/j.issn.1672-4992.2023.06.038
Abstract:
In the future 10 years,novel cancer therapeutics is booming.Optogenetics,timing,mechanogenetics,nerve,microbiota,microrobots,adaptive and digital therapeutics should further enter clinical treatment and improve patient outcomes.The future for oncology will be more personal,more precise and more intelligence.

References:

[1]SVEN ROTTENBERG,CARMEN DISLER,PAOLA PEREGO.The rediscovery of platinum-based cancer therapy[J].Nat Rev Cancer,2021,21(1):37-50.
[2]HIGH KA,RONCAROLO MG.Gene therapy[J].N Engl J Med,2019,381(5):455-464.
[3] JENNIFER A DOUDNA.The promise and challenge of therapeutic genome editing[J].Nature,2020,578(7794):229-236.
[4] BATES SE.Epigenetic therapies for cancer[J].N Engl J Med,2020,383(7):650-663.
[5] MICHAEL J TOPPER,MICHELLE VAZ,KRISTEN A MARRONE,et al.The emerging role of epigenetic therapeutics in immuno oncology[J].Nat Rev Clin Oncol,2020,17(2):75-90.
[6] BIANCA NOGRADY.The challenge of delivering RNA-interference therapeutics to their target cells[J].Nature,2019,574(7778):S8-S9.
[7] EVAN W WEBER,MARCELA V MAUS,CRYSTAL L MACKALL.The emerging landscape of immune cell therapies[J].Cell,2020,181(1):46-62.
[8] MIHE HONG,JUSTIN D CLUBB,YVONNE Y CHEN.Engineering CAR-T cells for next-generation cancer therapy[J].Cancer Cell,2020,38(4):473-488.
[9] ERIN A KIMBREL,ROBERT LANZA.Next-generation stem cells-ushering in a new era of cell-based therapies[J].Nat Rev Drug Discov,2020,19(7):463-479.
[10] MICHELLE MONJE,JEREMY C BORNIGER,NISHA JD'SILVA.Roadmap for the emerging field of cancer neuroscience[J].Cell,2020,181(2):219-222.
[11] BRIER MI,DORDICK JS.Remote activation of cellular signaling[J].Science,2020,368(6494):936-937.
[12] ZILIANG HUANG,YIQIAN WU,MOLLY E ALLEN.Engineering light-controllable CAR T cells for cancer immunotherapy[J].Sci Adv,2020,6(8):eaay9209.
[13] KENICHIRO KINOUCHI,PAOLO SASSONE-CORSI.Metabolic rivalry:Circadian homeostasis and tumorigenesis[J].Nat Rev Cancer,2020,20(11):645-661.
[14]BISHEHSARI F,KESHAVARZIAN A,VOIGT RM.Circadian rhythms and the gut microbiota:From the metabolic syndrome to cancer[J].Nat Rev Endocrinol,2020,16(12):731-739.
[15] NIA HT,MUNN LL,JAIN RK.Physical traits of cancer[J].Science,2020,370(6516):eaaz0868.
[16] ERIK SAHAI,IGOR ASTSATUROV,EDNA CUKIERMAN.A framework for advancing our understanding of cancer-associated fibroblasts[J].Nat Rev Cancer,2020,20(3):174-186.
[17]RIK DERYNCK,ROSEMARY J AKHURST,SHANNON J TURLEY.TGFβ biology in cancer progression and immunotherapy[J].Nat Rev Clin Oncol,2021,18(1):9-34.
[18] JIAN ZHANG,CYNTHIA A REINHART-KING.Targeting tissue stiffness in metastasis:mechanomedicine improves cancer therapy[J].Cancer Cell,2020,37(6):754-755.
[19] MICHELLE MONJE,JEREMY C BORNIGER,NISHA J D' SILVA.Roadmap for the emerging field of cancer neuroscience[J].Cell,2020,181(2):219-222.
[20] ALI H ZAHALKA,PAUL S FRENETTE.Nerves in cancer[J].Nat Rev Cancer,2020,20(3):143-157.
[21] IHSAN EKIN DEMIR,CARMEN MOTA REYES,WASFI ALRAWASHDEH.Clinically actionable strategies for studying neural influences in cancer[J].Cancer Cell,2020,38(1):11-14.
[22] JAVDAN B,LOPEZ JG,CHANKHAMJON P,et al.Personalized mapping of drug metabolism by the human gut microbiome[J].Cell,2020,181(7):1661-1679.e22.
[23] YUE QIAO,FEI YANG,TINGTING XIE.Engineered algae:A novel oxygen-generating system for effective treatment of hypoxic cancer[J].Sci Adv,2020,6(21):eaba5996.
[24] EREZ N BARUCH,ILAN YOUNGSTER,GUY BEN-BETZALEL,et al.Fecal microbiota transplant promotes response in immunotherapy-refractory melanoma patients[J].Science,2021,371(6529):602-609.
[25] CHRISTINE K SCHMIDT,MARIANA MEDINA-SANCHEZ,RICHARD J EDMONDSON.Engineering microrobots for targeted cancer therapies from a medical perspective[J].Nat Commun,2020,11(1):5618.
[26] SHARON M SAGNELLA,LU YANG,GEMMA E STUBBS.Cyto-immuno-therapy for cancer:A pathway elicited by tumor-targeted,cytotoxic drug-packaged bacterially derived nanocells[J].Cancer Cell,2020,37(3):354-370.
[27] ADRIAN BAEZ-ORTEGA,KEVIN GORI,ANDREA STRAKOVA,et al.Somatic evolution and global expansion of an ancient transmissible cancer lineage[J].Science,2019,365(6452):eaau9923.
[28] GATENBY RA,BROWN JS.Integrating evolutionary dynamics into cancer therapy[J].Nat Rev Clin Oncol,2020,17(11):675-686.
[29] SIMON MAKIN.The emerging world of digital therapeutics[J].Nature,2019,573(7775):S106-S109.
[30] ERIC J TOPOL.A decade of digital medicine innovation[J].Sci Transl Med,2019,11(498):eaaw7610.
[31] DOSSETT ML,FRICCHIONE GL,BENSON H.A new era for mind-body medicine[J].N Engl J Med,2020,382:1390-1391.
[32] JAMES T YURKOVICH,QIANG TIAN,NATHAN D PRICE,et al.A systems approach to clinical oncology uses deep phenotyping to deliver personalized care[J].Nat Rev Clin Oncol,2020,17(3):183-194.
[33] LO YH,KARLSSON K,KUO CJ.Applications of organoids for cancer biology and precision medicine[J].Nature Cancer,2020,1:761-773.
[34] CLARKE MA,FISHER J.Executable cancer models:Successes and challenges[J].Nat Rev Cancer,2020,20(6):343-354.
[35] MURCIANO-GOROFF YR,TAYLOR BS.Toward a more precise future for oncology[J].Cancer Cell,2020,37(4):431-442.
[36] DEAN HO.Artificial intelligence in cancer therapy[J].Science,2020,367(6481):982-983.
[37] LYNNE W ELMORE,SUSANNA F GREER,ELVAN C DANIELS,et al.Blueprint for cancer research:Critical gaps and opportunities[J].CA Cancer J Clin,2021,71(2):107-139.
[38] 张百红,岳红云.肿瘤研究的新方法学[J].西北国防医学杂志,2016,37(2):117-120. ZHANG BH,YUE HY.New methods in cancer research[J].Med J NDFNC,2016,37(2) :117-120.

Memo

Memo:
联勤保障部队第九四〇医院课题(编号:2021yxky052)
Last Update: 1900-01-01